Arrowhead Research reported $499.25M in Assets for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Agios Pharmaceuticals AGIO:US $ 852.95M 55.5M
Alnylam Pharmaceuticals ALNY:US $ 3407.06M 99.78M
Arena Pharmaceuticals ARNA:US $ 1190.72M 84.82M
Arrowhead Research ARWR:US $ 499.25M 23.25M
Bluebird Bio BLUE:US $ 1781.25M 164.23M
Cerulean Pharma CERU:US $ 7.66M 0.91M
Dicerna Pharmaceuticals DRNA:US $ 707.85M 26.11M
Heron Therapeutics HRTX:US $ 353.56M 36.47M
Intercept Pharmaceuticals ICPT:US $ 580.49M 10.86M
Ligand Pharmaceuticals LGND:US $ 1362.28M 114.84M
Merk MRK:US $ 91588M 1788M
Mirati Therapeutics MRTX:US $ 1476.13M 856.28M
Moderna Inc MRNA:US 7.34B 2.69B
Nektar Therapeutics NKTR:US $ 1538.77M 30.1M
Novartis NOVN:VX SF 132059M 2381M
Opko Health OPK:US $ 2473.06M 101.77M
Spectrum Pharmaceuticals SPPI:US $ 237.94M 43.68M
Ultragenyx Pharmaceutical RARE:US $ 1759.56M 491.17M
Vertex Pharmaceuticals VRTX:US $ 11751.81M 450.18M
Xencor XNCR:US $ 703.24M 56.9M
YTE INCY:US $ 3560.92M 253.49M